International Review of Ophthalmology ›› 2024, Vol. 48 ›› Issue (1): 69-74.doi: 10.3760/ cma.j.issn.1673-5803.2024.01.014

Previous Articles     Next Articles

The mechanism of pathogenesis and treatment of myopic traction maculopathy

Bai Yang, Li Haoru, Sui Jinyuan, Wei Ruihua   

  1. Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China

  • Received:2023-07-11 Online:2024-02-25 Published:2024-02-28
  • Contact: Wei Ruihua, Email: rwei@tmu.edu.cn
  • Supported by:
     National Natural Science Foundation of China (82070929); Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-037A)  DOI: 10.3760/ cma.j.issn.1673-5803.2024.01.014

Abstract:

Myopic traction maculopathy(MTM)is a primary complication that causes blindness in patients with high myopia. Anterior retinal traction (vitreous traction, anterior retinal traction, and inner limiting membrane traction), posterior retinal traction (posterior scleral staphyloma, axial elongation), and retinal factors are thought to be the main mechanisms in its pathogenesis.The treatment of myopic traction maculopathy is mainly surgery, and there are different surgical options for different traction forces, such as pars plana vitrectomy, internal limiting membrane removal, epiretinal membrane removal, posterior scleral reinforcement and macular buckling, etc. (Int Rev Ophthalmol, 2024, 48:  69-74)


Key words: high myopia, traction maculopathy